eClinical Technology and Industy News

Canada gives full approval to J&J’s single-shot COVID-19 vaccine

Excerpt from the Press Release:

Nov 24 (Reuters) – Johnson & Johnson (JNJ.N) said on Wednesday Canada gave full approval to its single-shot COVID-19 vaccine for people aged 18 years and older, making it the first full approval for the vaccine globally.

The vaccine was previously authorised by the country under an interim order. (https://refini.tv/30Zd5TR)

Canada, which is reporting 2,563 infections on average each day and has administered at least 60,101,058 doses of COVID-19 vaccines so far, gave full approval to Moderna Inc (MRNA.O) and Pfizer Inc’s (PFE.N) coronavirus vaccines in September.

The country authorised the use of Pfizer’s COVID-19 vaccine for children aged 5 to 11 and a booster dose for people aged 18 years and older this month. read more

J&J’s coronavirus vaccine has been authorised for emergency use in many countries, including the United States.

Click the button below to read the entire Press Release:

Continue Reading The Press Release

Discover What Sets TrialStat Apart From Ordinary Data Management

Click the image or button below to explore our interactive infographic which illustrates the comprehensive and unique capabilities of the TrialStat eClinical Suite.

Request Your Demo Today!

From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?

Archives